📊 HGYN Key Takeaways
Is HGYN a Good Investment? Thesis Analysis
Hong Yuan Holding Group exhibits signs of technical insolvency with negative shareholders' equity of -$112.1K and liabilities exceeding assets by $46.2K. The company faces a severe liquidity crisis with current ratio of 0.85x, negative operating cash flow of -$28.8K, and negative free cash flow of -$31.8K, unable to service obligations. Revenue has collapsed 72.5% YoY to just $612.2K, and with only $12.6K in cash against $476.4K in liabilities, the company lacks viable path to solvency without major restructuring or external capital infusion.
Why Buy HGYN? Key Strengths
- Maintains positive net income of $116.2K despite minimal revenue base
- Strong gross margin of 63.8% suggests underlying business model profitability if scale could be achieved
- Operating margin of 21.9% demonstrates cost control on existing operations
HGYN Investment Risks to Consider
- Negative shareholders' equity of -$112.1K indicates technical insolvency and balance sheet bankruptcy
- Current ratio of 0.85x and quick ratio of 0.79x signal inability to meet current obligations
- Negative operating and free cash flow of -$28.8K and -$31.8K respectively with minimal cash buffer of $12.6K creates imminent liquidity risk
- Revenue collapsed 72.5% YoY indicating severe business deterioration and potential market rejection
- No insider activity in 90 days combined with OTC trading suggests limited stakeholder confidence and illiquidity
Key Metrics to Watch
- Operating cash flow - must turn positive to indicate operational sustainability
- Cash balance relative to liabilities - critical monitoring given $12.6K cash vs $476.4K liabilities
- Revenue stabilization - must reverse the 72.5% YoY decline
- Shareholders equity - must return to positive territory to restore solvency
HGYN Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
HGYN Profitability Ratios
HGYN vs Default Sector
How HONG YUAN HOLDING GROUP compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is HGYN Overvalued or Undervalued?
Based on fundamental analysis, HONG YUAN HOLDING GROUP has mixed fundamental signals relative to the Default sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
HGYN Balance Sheet & Liquidity
HGYN 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: HONG YUAN HOLDING GROUP's revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $0.00 indicates the company is currently unprofitable.
HGYN Growth Metrics (YoY)
HGYN Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $85 | $48.6K | $0.00 |
| Q2 2025 | $15.2K | -$22.9K | $0.00 |
| Q1 2025 | $241.1K | $37.5K | $0.00 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
HGYN Capital Allocation
HGYN SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for HONG YUAN HOLDING GROUP (CIK: 0001324759)
📋 Recent SEC Filings
❓ Frequently Asked Questions about HGYN
What is the AI rating for HGYN?
HONG YUAN HOLDING GROUP (HGYN) has an AI rating of STRONG SELL with 90% confidence, based on fundamental analysis of SEC EDGAR filings.
What are HGYN's key strengths?
Claude: Maintains positive net income of $116.2K despite minimal revenue base. Strong gross margin of 63.8% suggests underlying business model profitability if scale could be achieved.
What are the risks of investing in HGYN?
Claude: Negative shareholders' equity of -$112.1K indicates technical insolvency and balance sheet bankruptcy. Current ratio of 0.85x and quick ratio of 0.79x signal inability to meet current obligations.
What is HGYN's revenue and growth?
HONG YUAN HOLDING GROUP reported revenue of $612.2K.
Does HGYN pay dividends?
HONG YUAN HOLDING GROUP does not currently pay dividends.
Where can I find HGYN SEC filings?
Official SEC filings for HONG YUAN HOLDING GROUP (CIK: 0001324759) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is HGYN's EPS?
HONG YUAN HOLDING GROUP has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is HGYN a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, HONG YUAN HOLDING GROUP has a STRONG SELL rating with 90% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is HGYN stock overvalued or undervalued?
Valuation metrics for HGYN: ROE of N/A (sector avg: 15%), net margin of 19.0% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy HGYN stock in 2026?
Our dual AI analysis gives HONG YUAN HOLDING GROUP a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability above sector average. Always conduct your own research.
What is HGYN's free cash flow?
HONG YUAN HOLDING GROUP's operating cash flow is $-28.8K, with capital expenditures of $3.0K. FCF margin is -5.2%.
How does HGYN compare to other Default stocks?
Vs Default sector averages: Net margin 19.0% (avg: 12%), ROE N/A (avg: 15%), current ratio 0.85 (avg: 1.8).